Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 81 (2) , 355-360
- https://doi.org/10.1016/j.fertnstert.2003.08.012
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Obesity and the polycystic ovary syndromeInternational Journal of Obesity, 2002
- Induction of ovulation in infertile women with hyperandrogenism and insulin resistanceAmerican Journal of Obstetrics and Gynecology, 2000
- Effect of Long-Term Treatment with Metformin Added to Hypocaloric Diet on Body Composition, Fat Distribution, and Androgen and Insulin Levels in Abdominally Obese Women with and without the Polycystic Ovary SyndromeJournal of Clinical Endocrinology & Metabolism, 2000
- Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary SyndromeNew England Journal of Medicine, 1998
- Metformin therapy improves the menstrual pattern with minimal endocrine and metabolic effects in women with polycystic ovary syndromeFertility and Sterility, 1998
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary SyndromeNew England Journal of Medicine, 1996
- Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the type-I insulin-like growth factor receptor.Journal of Clinical Endocrinology & Metabolism, 1995
- Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancyMetabolism, 1994
- A Mathematical Model for the Determination of Total Area Under Glucose Tolerance and Other Metabolic CurvesDiabetes Care, 1994